Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

132
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
132
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

122
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
122

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Frontiers in immunology·2026
Same author

Cancer in migrant populations: evidence from a regional oncology network.

BMC public health·2026
Same author

RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy.

Pathologica·2025
Same author

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

Vaccines·2023
Same author

Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.

International journal of molecular sciences·2022
Same author

RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.

Personalized medicine·2022

Related Experiment Video

Updated: Aug 16, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

883

Pancreatic Cancer: Beyond Brca Mutations.

Vincenzo Ricci1, Teresa Fabozzi2, Maria Anna Bareschino1

  • 1Medical Oncology Unit, AORN "San Pio", 82100 Benevento, Italy.

Journal of Personalized Medicine
|December 23, 2022
PubMed
Summary

This review explores genetic and epigenetic changes in metastatic pancreatic cancer, beyond BRCA mutations. Understanding these alterations may reveal new molecular targets for improved patient treatment and outcomes.

Keywords:
BRCA mutationPARP inhibitormetastatic pancreatic cancerpathwaytarget therapy

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.9K

Related Experiment Videos

Last Updated: Aug 16, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

883
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.3K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.9K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Pancreatic cancer is a leading cause of cancer mortality globally, with poor patient outcomes.
  • Existing treatments for metastatic pancreatic cancer have limited efficacy.
  • Genetic and epigenetic alterations play a crucial role in pancreatic cancer development and progression.

Purpose of the Study:

  • To review the genetic and epigenetic landscape of metastatic pancreatic cancer, excluding BRCA mutations.
  • To identify key molecular alterations and their pathological significance.
  • To highlight potential molecular targets for future pancreatic cancer therapies.

Main Methods:

  • Comprehensive literature review of genetic and epigenetic studies in metastatic pancreatic cancer.
  • Analysis of molecular pathology and genetic alterations.
  • Correlation of molecular targets with potential treatment strategies.

Main Results:

  • Detailed summary of genetic alterations beyond BRCA mutations in metastatic pancreatic cancer.
  • Elucidation of the molecular pathology associated with these alterations.
  • Identification of specific molecular targets for therapeutic intervention.

Conclusions:

  • Understanding the genetic and epigenetic architecture is crucial for advancing pancreatic cancer treatment.
  • Targeting specific molecular pathways may lead to personalized treatment strategies.
  • This knowledge can help identify patient subsets with distinct biological behaviors and treatment responses.